ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 303,28
0,66%
Dow Jones
45 014,04
0,69%
DAX
20 232,14
0,98%
Brent Oil
72,24
-0,26%
Bitcoin
101 068,50
2,34%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. I MAB (IMAB)

  7. I MAB (IMAB) Actualités

IMAB

I MAB (IMAB)

I MAB
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:IMAB
DateHeureSourceTitreSymboleSociété
21/11/202413h00PR Newswire (US)I-Mab to Participate at the Piper Sandler Healthcare ConferenceNASDAQ:IMABI MAB
14/11/202413h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
14/11/202413h00PR Newswire (US)I-Mab Reports Third Quarter 2024 ResultsNASDAQ:IMABI MAB
06/11/202413h00PR Newswire (US)I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive OfficerNASDAQ:IMABI MAB
31/10/202412h00PR Newswire (US)I-Mab to Release Q3 2024 Financial Results on November 14, 2024NASDAQ:IMABI MAB
30/10/202412h00PR Newswire (US)I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024NASDAQ:IMABI MAB
28/10/202412h00PR Newswire (US)I-Mab to Participate at the Truist Securities BioPharma SymposiumNASDAQ:IMABI MAB
16/09/202422h01PR Newswire (US)I-Mab Presents Updated Phase 1 Givastomig Data at ESMO 2024NASDAQ:IMABI MAB
10/09/202413h00PR Newswire (US)I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung CancerNASDAQ:IMABI MAB
28/08/202413h00PR Newswire (US)I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business UpdatesNASDAQ:IMABI MAB
26/08/202413h00PR Newswire (US)I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:IMABI MAB
14/08/202413h00PR Newswire (US)I-Mab to Release 1H 2024 Financial Results on August 28, 2024NASDAQ:IMABI MAB
07/08/202413h00PR Newswire (US)I-Mab Appoints U.S. Auditor, PricewaterhouseCoopers LLP (PwC)NASDAQ:IMABI MAB
26/07/202412h20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
15/07/202413h30PR Newswire (US)I-Mab Announces Leadership TransitionsNASDAQ:IMABI MAB
06/06/202413h00PR Newswire (US)I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical OfficerNASDAQ:IMABI MAB
05/06/202413h00PR Newswire (US)I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal CancersNASDAQ:IMABI MAB
30/05/202423h33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IMABI MAB
23/05/202423h05GlobeNewswire Inc.I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024NASDAQ:IMABI MAB
22/05/202413h00PR Newswire (US)I-Mab to Participate at the Jefferies Global Healthcare ConferenceNASDAQ:IMABI MAB
30/04/202413h00PR Newswire (US)I-MAB Filed 2023 Annual Report on Form 20-FNASDAQ:IMABI MAB
05/04/202413h00PR Newswire (US)I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:IMABI MAB
02/04/202422h01PR Newswire (US)I-Mab Announces Closing of the Divestiture of Business Operations in ChinaNASDAQ:IMABI MAB
14/03/202422h00PR Newswire (US)I-Mab Reports Full Year 2023 Financial Results and Business UpdateNASDAQ:IMABI MAB
09/02/202422h01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IMABI MAB
07/02/202412h00PR Newswire (US)I-Mab Signs Agreement to Divest its Assets and Business Operations in ChinaNASDAQ:IMABI MAB
07/02/202402h55Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:IMABI MAB
02/01/202423h08Dow Jones NewsADRs Slump; FLJ Group Declines 21%NASDAQ:IMABI MAB
01/12/202320h41Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:IMABI MAB
06/11/202314h00PR Newswire (US)I-Mab Announces Participation at Jefferies and Piper Conferences in NovemberNASDAQ:IMABI MAB
 Showing the most relevant articles for your search:NASDAQ:IMAB

Dernières Valeurs Consultées

NYSE
MRK
Merck
EU
BEL20
Bel 20
EU
PX1
CAC 40
NASDAQ
AMZN
Amazon.com
EU
BNP
BNP Paribas
EU
HO
Thales
NYSE
DIS
Walt Disney
EU
ACA
Credit Agricole
EU
ML
Michelin
EU
RI
Pernod Ricard
COIN
AVAXUSD
Avalanche
NASDAQ
GOOGL
Alphabet
EU
PX4
SBF 120
COIN
ADAUSD
Cardano
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés